Pressure BioSciences, Inc. (PBIO)
PBIO Stock Price Chart
Explore Pressure BioSciences, Inc. interactive price chart. Choose custom timeframes to analyze PBIO price movements and trends.
PBIO Company Profile
Discover essential business fundamentals and corporate details for Pressure BioSciences, Inc. (PBIO) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Devices
IPO Date
31 Oct 1996
Employees
15.00
CEO
Richard T. Schumacher
Description
Pressure BioSciences, Inc. develops and sells pressure-based platform solutions in the North America, Europe, and Asia. The company's pressure cycling technology (PCT) technology uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to control the actions of molecules in biological samples, including cells and tissues from human, animal, plant, and microbial sources. It offers Barocycler instrumentations comprising Barocycler 2320EXT, Barocycler HUB880, Barocycler HUB440, and The Shredder SG3. The company also distributes cell disruption equipment, parts, and consumables. In addition, it offers Barocycler consumable products, such as PCT MicroTubes, PCT MicroCaps, PCT-Micro Pestle, and pressure used to lyse samples for extraction tubes, as well as application specific kits, including consumable products and reagents. The company serves researchers at academic laboratories, government agencies, biotechnology companies, pharmaceutical firms, and other life science institutions. It has collaborations with RedShiftBio Inc.; Inova Schar Cancer Center; NYU; Leica Microsystems, GmbH; Steinbeis Centre for biopolymer analysis and biological mass spectrometry; The Ohio State University; University of Delaware; and Cedars Sinai Medical Center. The company was formerly known as Boston Biomedica, Inc. Pressure BioSciences, Inc. was incorporated in 1978 and is based in South Easton, Massachusetts. As of August 2, 2022, Pressure BioSciences, Inc. operates as a subsidiary of Emergent Health Corp.
PBIO Financial Timeline
Browse a chronological timeline of Pressure BioSciences, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 5 Feb 2026
Earnings released on 4 Sept 2025
Earnings released on 5 Jun 2025
Earnings released on 5 Jun 2025
Earnings released on 7 Feb 2025
EPS came in at -$0.15 .
Earnings released on 14 Nov 2024
Earnings released on 6 Sept 2024
EPS came in at -$0.22 , while revenue for the quarter reached $421.79K , missing expectations by -92.74%.
Earnings released on 7 Jun 2024
EPS came in at -$0.30 , while revenue for the quarter reached $349.26K , missing expectations by -93.99%.
Earnings released on 5 Feb 2024
EPS came in at -$0.28 , while revenue for the quarter reached $312.35K .
Earnings released on 20 Nov 2023
EPS came in at -$0.29 , while revenue for the quarter reached $413.01K , missing expectations by -92.89%.
Earnings released on 21 Aug 2023
EPS came in at -$0.57 , while revenue for the quarter reached $511.80K .
Earnings released on 18 Apr 2023
EPS came in at -$0.26 , while revenue for the quarter reached $607.17K .
Earnings released on 12 Apr 2023
EPS came in at -$0.37 , while revenue for the quarter reached $740.60K .
Earnings released on 22 Nov 2022
EPS came in at -$0.44 , while revenue for the quarter reached $144.03K .
Earnings released on 15 Aug 2022
EPS came in at -$0.32 , while revenue for the quarter reached $498.14K .
Earnings released on 19 May 2022
EPS came in at -$0.48 , while revenue for the quarter reached $480.00K .
Earnings released on 5 Apr 2022
EPS came in at -$0.40 , while revenue for the quarter reached $315.20K .
Earnings released on 17 Nov 2021
EPS came in at -$0.82 , while revenue for the quarter reached $518.37K .
Earnings released on 18 Aug 2021
EPS came in at -$0.90 , while revenue for the quarter reached $608.93K .
Earnings released on 17 May 2021
EPS came in at -$1.35 , while revenue for the quarter reached $559.87K .
Earnings released on 15 Apr 2021
EPS came in at -$1.10 , while revenue for the quarter reached $164.70K .
Earnings released on 17 Nov 2020
EPS came in at -$1.02 surpassing the estimated -$2.20 by +53.64%, while revenue for the quarter reached $533.86K .
PBIO Stock Performance
Access detailed PBIO performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.